| # | Drug | Count |
|---|---|---|
| 0 | VENETOCLAX | 23 |
| 1 | AZACITIDINE | 20 |
| 2 | CYCLOPHOSPHAMIDE | 17 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 17 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 17 |
| 5 | DEXAMETHASONE | 15 |
| 6 | DEXAMETHASONE 1.5 MG | 15 |
| 7 | DOXORUBICIN | 13 |
| 8 | AZACITIDINE FOR | 11 |
| 9 | METHOTREXATE SODIUM | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAGRAXOFUSP | 10 | 0.0186 |
| 1 | PRALATREXATE | 1 | 0.0015 |
| 2 | PURIXAN | 1 | 0.0013 |
| 3 | RYDAPT | 2 | 0.0010 |
| 4 | DECITABINE | 3 | 0.0007 |
| 5 | AZACITIDINE | 20 | 0.0007 |
| 6 | DAUNORUBICIN HYDROCHLORIDE | 1 | 0.0006 |
| 7 | FEBUXOSTAT TABLETS 40 MG | 5 | 0.0005 |
| 8 | RASBURICASE | 1 | 0.0004 |
| 9 | VENETOCLAX | 23 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 31 |
| 1 | BCL-2 Inhibitor [EPC] | 23 |
| 2 | Corticosteroid [EPC] | 20 |
| 3 | Alkylating Drug [EPC] | 19 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 11 |
| 5 | CD123 Interaction [EPC] | 10 |
| 6 | Cytotoxin [EPC] | 10 |
| 7 | Topoisomerase Inhibitor [EPC] | 9 |
| 8 | Proteasome Inhibitor [EPC] | 8 |
| 9 | Azole Antifungal [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD123 Interaction [EPC] | 10 | 0.0186 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 2 | BCL-2 Inhibitor [EPC] | 23 | 0.0004 |
| 3 | Cannabinoid [EPC] | 1 | 0.0001 |
| 4 | Topoisomerase Inhibitor [EPC] | 9 | 0.0001 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 31 | 0.0001 |
| 6 | Alkylating Drug [EPC] | 19 | 0.0001 |
| 7 | Proteasome Inhibitor [EPC] | 8 | 0.0001 |
| 8 | Azole Antifungal [EPC] | 7 | 0.0000 |
| 9 | Erythropoiesis-stimulating Agent [EPC] | 2 | 0.0000 |